Veriheal

NOVEMBER 18, 2022

Texas’ consistent gains can, in large part, be attributed to its recent efforts to increase access to its program. In September, the state expanded its list of qualifying conditions , allowing veterans with PTSD and cancer patients to join the program. Hemp Study Shows Challenges of Regulation.

Edibles 97

Edibles Hemp Epilepsy Programs 97

Cannabis Law Report

JULY 24, 2019

But it is important that access to it is delivered in a way that fits in with other treatment options. Our clinics are based on the premise that patients are treated by our world-renowned specialists in the relevant condition. It will primarily work on a second opinion basis accepting referrals from GPs and other specialists.

Epilepsy 40

Epilepsy Medicine Treatment Patients 40

The Cannigma

MARCH 14, 2023

Cancer, HIV, epilepsy and other serious conditions were the first accepted uses of cannabis in the United States. Many of the early medical cannabis states had strict lists of conditions for which cannabis could be legally used. This included whether they had access to educational information about cannabis.

Policy 96

Policy Research and Development Conditions Consumption 96

Medicinal Marijuana Association

FEBRUARY 10, 2024

Differentiate between fact and fiction by accessing trustworthy information. Implement research findings by consulting experts and translating data into practical actions. By analyzing these studies, you can gain insights into the effects of cannabis on various medical conditions, such as chronic pain, epilepsy, and anxiety.

Research and Development 52

Research and Development Data Chronic Pain Conditions 52

MassRoots

MARCH 5, 2019

Cannabidiol ( CBD ), the non-psychoactive cannabinoid praised for medicinal powers like reducing the severity and frequency of seizures in children suffering from rare and otherwise untreatable forms of epilepsy, may not be the most medically beneficial molecule found in cannabis, according to new data. Data Tracking.

THC 111

THC CBD Data Cannabinoids 111

Cannabis Law Report

JULY 25, 2022

Medical marijuana is legal in Pennsylvania but it can be accessed only by registered patients with a medical marijuana card. Medical marijuana is only legal for those who suffer from a qualifying medical condition. You must make sure that your condition qualifies and go through the application process. . Anxiety disorders.

Legalization 52

Legalization Marijuana Epilepsy Sativa 52

Canna Law Blog

DECEMBER 16, 2021

Expansive List of Qualifying Medical Conditions. Data from the RAND Corporation show that 8,000 New York veterans from the Wars in Iraq and Afghanistan suffer from PTSD. Oregon, Texas, and several cities have taken similar steps to increase access to psilocybin treatment.

Legislation 97

Legislation Treatment Therapy Conditions 97

The Cannigma

JUNE 15, 2021

The first clinical research done on CBD as a potential treatment for epilepsy was in 1980, but the information gleaned didn’t make its way to the public eye until decades later. However, the scientific data on CBG is nowhere near as developed as what we have on CBD. Shutterstock). One of the leading cannabis clinicians in the U.S.,

CBD 122

CBD Research and Development Epilepsy Extraction 122

CannaTech

AUGUST 9, 2018

We are delighted to introduce you to some new friends set to make a big impact on the medical cannabis advocacy scene… the creators of a new documentary called Separating the Strains ; a deeply personal narrative that charts the reality of living with epilepsy, with and without cannabis medication as a treatment option.

Strains 69

Strains Epilepsy Advocacy Medicine 69

Kind Meds (Cannabis Education Blog)

NOVEMBER 18, 2020

It seems like the medical research community remains largely divided on the issue, with some insisting that cannabis use contributes to mental health condition diagnoses while others suggesting that people with mental health conditions are inherently drawn to cannabis use.

Treatment 111

Treatment Conditions CBD Clinical Trials 111

Cannabis Law Report

DECEMBER 1, 2019

A young girl with a drug-resistant form of epilepsy is believed to be the first and only patient in Singapore who has been given approval to use cannabis-derived medication. The move follows approvals by lawmakers in the United States to use the medication to treat rare kinds of childhood epilepsy in that country.

Epilepsy 59

Epilepsy Cannabinoids Therapy Treatment 59

Veriheal

MAY 31, 2022

According to data released by the Centers for Disease Control and Prevention , there were an estimated 2,620 opioid overdose deaths in Texas between Aug. Expanded Qualifying Conditions. Of the issues with Texas’ Compassionate Use Program, perhaps the most significant is its short list of qualifying conditions. More Telemedicine.

Programs 52

Programs Chronic Pain Treatment Conditions 52

Canna Care Docs

DECEMBER 16, 2020

Medical marijuana is the use of the marijuana plant or its chemicals to treat various diseases or conditions. The difference is that medical patients may have access to higher dosages, among other benefits depending on their state, and receive a higher level of service to match them with the best products for their symptoms.

Chronic Pain 52

Chronic Pain Marijuana Clinical Trials Epilepsy 52

CannaTech

SEPTEMBER 16, 2018

Doctors have remained integral parts of a patient’s cannabis journey through what is known as the Access to Cannabis for Medical Purposes Regulation (ACMPR) act. These guidelines outline a list of qualifying conditions that patients must possess in order to legally obtain medical cannabis. Shedding Stigma and Promoting Patient Access.

Education 66

Education Medicine Clinical Trials Patients 66

Veriheal

APRIL 11, 2022

We know that the plant has powerful potential medical effects, but it clearly needs more refinement, more research and more data,” stated Groff, who envisions a future where patients can easily access ailment-targeted cannabis meds. This means that U.S. Drug Enforcement Agency (DEA).

Pharmaceutical 104

Pharmaceutical Research and Development DEA Clinical Trials 104

Cannabis Cheri

APRIL 1, 2022

In fact, a lot of people don’t realize that the keto diet was originally designed to treat seizures in children suffering from treatment resistant epilepsy. Not everyone encounters this annoying condition, but many people starting a keto diet do. As always, more research and more data is needed to know for sure. Read more here.

Edibles 203

Edibles Cannabis Cannabinoids Oil 203

Cannabis Law Report

DECEMBER 7, 2021

This trend is also observed in the pediatric population, where MCs are authorized in children for refractory epilepsy, especially in Dravet syndrome and Lennox-Gastaut syndrome 2. A systematic review published in 2017 aimed to identify available data about the therapeutic effect of cannabinoids treatment in children and adolescents.

Safety 52

Safety Cannabinoids Events Data 52

Leaf Science

JULY 23, 2019

In the UK, cannabis was legalized for medicinal purposes in 2018 which saw patients of epilepsy and multiple sclerosis able to access pharmaceutical cannabis derivatives such as Sativex and Epidiolex. Cannabis & general health. It wouldn’t have got the level of 1.3

Strains 74

Strains Cannabinoids Epilepsy THC 74

CannaMD

SEPTEMBER 15, 2020

MORE DETAILS: On June 16, 2014, Florida became the 22nd state to legalize (at least partial) access to medical marijuana when Governor Rick Scott signed the Compassionate Medical Cannabis Act of 2014. SHORT ANSWER: Full-time and seasonal Florida residents who suffer from an eligible medical condition. ” Translation?

Law 126

Law Marijuana Patients Treatment 126

Veriheal

FEBRUARY 10, 2022

cloudPWR and Accela’s cloud-based registry has been publicly accessible since Nov. Data and storage options via the integrated Microsoft Azure platform. The DOH maintains the right to add other medical conditions to the following list of eligible conditions for medical cannabis in South Dakota: AIDS/HIV. Crohn’s disease.

Programs 52

Programs Chronic Pain Patients Conditions 52

Cannabis Law Report

AUGUST 17, 2021

Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced topline data from its open-label Phase 2 trial evaluating safety and efficacy of adjunctive oral ganaxolone treatment in 23 patients with seizures associated with tuberous sclerosis complex (TSC).

Pharmaceutical 98

Pharmaceutical Clinical Trials Treatment Patients 98

Veriheal

OCTOBER 5, 2020

The bill set out the qualifying conditions as well as regulations relating to possession, cultivation, and dispensaries. It could be speculated that the bud still accounts for the majority of cannabis consumption due to the fact that it is easier to access in areas where cannabis has not yet been legalized or decriminalized. .

Edibles 52

Edibles Legalization Decriminalization Consumption 52

Cannabis Law Report

SEPTEMBER 24, 2019

T he EU has approved for the first time the use of a medicinal cannabis product aimed at patients with two rare, but severe, forms of childhood epilepsy. The medication, developed by GW Pharmaceuticals, will be used in combination with another epilepsy medication called clobazam. What about other medical cannabis products? PDF Version.

Pharmaceutical 55

Pharmaceutical Epilepsy Research and Development Medicine 55

Cannabis Law Report

JUNE 26, 2019

Minister for Health Simon Harris TD today signed legislation which will allow for the operation of the Medical Cannabis Access Programme on a pilot basis for five years. The Programme will facilitate access to cannabis-based products for medical use in line with legislation. We have highlighted relevant passages.

Medicine 55

Medicine Access Business Legislation 55

Cannabis Law Report

FEBRUARY 17, 2020

The Committee will convene telephonically and in-person bimonthly to develop ways and methods to expand patient access and affordability, increase innovation and technology within the cannabis industry, and to make recommendations to the Legislature and the Department of Health’s Office of Medical Marijuana Use (OMMU).

Dispensary 76

Dispensary Patients Agriculture Conditions 76

Puff Puff Post

MARCH 2, 2020

. · Export quotas allow for the manufacture of whole plant extract for international purposes to countries such as Peru, Uruguay, and Brazil, thereby accessing to a medical cannabis market of $1.4 ” Comments Juan Diego Alvarez, Khiron Vice-President of Regulatory Affairs.

Extraction 52

Extraction THC Chronic Pain Cultivation 52

Veriheal

AUGUST 31, 2020

Essay Summary: Nishtha wants to further research into THC treatment for patients suffering from neurodegenerative diseases like Alzheimer’s and epilepsy , both of which cause neuron death. Essay: “Crowdsourcing User Experience Data for a Targeted Medical Cannabis Journey with Cannamunity” . School: Tufts University.

Research and Development 117

Research and Development Education Agriculture Patients 117

Cannabis Law Report

DECEMBER 9, 2019

That said, research conducted to date has been promising, with CBD demonstrating the potential for aiding with a wide range of health conditions and resulting symptoms. Like humans, pets also feel anxiety, pain, and suffer from chronic conditions such as arthritis. Anxiety and Inflammation Lead the Pack. Cautious Optimism for Pet CBD.

Pets 59

Pets CBD Research and Development Epilepsy 59

WeedAdvisor

APRIL 8, 2019

With this kind of accessibility, CBD’s popularity skyrocketed in all 50 states. The only actual confirmed benefit of CBD is its effect on Lennox Gastaut Syndrome and Dravet Syndrome – two severe types of epilepsy that do not typically respond to conventional treatment. But again, these are based on little data that is mostly anecdotal.

Food 40

Food CBD Research and Development Treatment 40

Greencamp

AUGUST 16, 2018

The available body of evidence suggests that besides the lessening of symptoms, cannabis is also capable of slowing down the overall rate of progression of this horrible condition. Modern science hasn’t found a cure for this condition so far, and the most frequent cause of death is respiratory failure due to muscle decay.

Strains 94

Strains Cannabinoids Research and Development Indica 94

Puff Puff Post

MARCH 2, 2020

. · Export quotas allow for the manufacture of whole plant extract for international purposes to countries such as Peru, Uruguay, and Brazil, thereby accessing to a medical cannabis market of $1.4 ” Comments Juan Diego Alvarez, Khiron Vice-President of Regulatory Affairs.

Extraction 40

Extraction THC Chronic Pain Cultivation 40

Cannabis Law Report

MAY 6, 2022

Generally, a CBD product seller is expected (or required by law) to provide customers with access to a “certificate of analysis” or “COA” associated with specific products, which COA confirms the levels of CBD in products and upon which customers can rely. High level CBD can help manage symptoms of psychosis.”. Taking CBD can relieve pain.”.

THC 52

THC CBD Media Food 52

Project CBD

FEBRUARY 28, 2023

HerbalGram, the acclaimed quarterly journal of the American Botanical Council, recently published its 2021 “Herb Market Report,” which included data on sales of CBD as an herbal ingredient in mainstream and natural retail channels in the United States. Accessed July 25, 2021. Available at: [link] Accessed October 17, 2022.

CBD 144

CBD Seed-To-Sale Food Access 144

Cannabis Law Report

NOVEMBER 16, 2021

Phase 2 trial recruiting begins immediately; efficacy data expected by the end of the first quarter of 2022. Recruitment for the Phase 2 trial will begin immediately, and efficacy data is expected by the end of first quarter of 2022. “To BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc.

Pharmaceutical 52

Pharmaceutical Clinical Trials Research and Development Therapy 52

Puff Puff Post

JANUARY 1, 2020

As a result, medical usage now grows substantially now that doctors and hospitals have access to legal cannabis. Treatment for many serious medical conditions can be very expensive, and drugs that have no government approval do not get insurance coverage. Patients with a dvanced cases of cancer or HIV lose weight and vomit.

Treatment 64

Treatment Clinical Trials Research and Development Cannabinoids 64

Greenspoon Marder Cannabis Law Group Blog

APRIL 2, 2019

For example, we’re seeking comments, data and information on a variety of topics including: what levels of cannabis and cannabis-derived compounds cause safety concerns; how the mode of delivery (e.g., Examples of claims made by these companies include: “CBD successfully stopped cancer cells in multiple different cervical cancer varieties.”.

CBD 40

CBD Research and Development Safety Therapy 40

Puff Puff Post

JANUARY 1, 2020

As a result, medical usage now grows substantially now that doctors and hospitals have access to legal cannabis. Treatment for many serious medical conditions can be very expensive, and drugs that have no government approval do not get insurance coverage. Patients with a dvanced cases of cancer or HIV lose weight and vomit.

Treatment 40

Treatment Clinical Trials Research and Development Cannabinoids 40